Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 23 | 2024 | 2125 | 3.260 |
Why?
|
Heterocyclic Compounds, 3-Ring | 9 | 2024 | 278 | 2.410 |
Why?
|
Botswana | 35 | 2024 | 1040 | 2.340 |
Why?
|
Anti-Retroviral Agents | 13 | 2024 | 1780 | 2.090 |
Why?
|
HIV Infections | 41 | 2024 | 17275 | 2.060 |
Why?
|
Infectious Disease Transmission, Vertical | 12 | 2023 | 1348 | 2.020 |
Why?
|
Premature Birth | 16 | 2023 | 1771 | 1.720 |
Why?
|
Pregnancy Outcome | 19 | 2024 | 2907 | 1.710 |
Why?
|
Neural Tube Defects | 3 | 2019 | 254 | 1.660 |
Why?
|
Benzoxazines | 4 | 2020 | 309 | 1.200 |
Why?
|
Oxazines | 9 | 2024 | 341 | 1.170 |
Why?
|
HIV Seropositivity | 3 | 2023 | 960 | 1.010 |
Why?
|
Pregnancy | 48 | 2024 | 29742 | 0.890 |
Why?
|
Pyridones | 8 | 2024 | 784 | 0.800 |
Why?
|
Abnormalities, Drug-Induced | 3 | 2024 | 338 | 0.790 |
Why?
|
Infant Mortality | 3 | 2016 | 757 | 0.790 |
Why?
|
Maternal-Fetal Relations | 1 | 2021 | 25 | 0.790 |
Why?
|
Stillbirth | 12 | 2024 | 368 | 0.780 |
Why?
|
Anti-HIV Agents | 10 | 2024 | 4504 | 0.770 |
Why?
|
Placentation | 1 | 2021 | 78 | 0.760 |
Why?
|
HIV Integrase Inhibitors | 2 | 2019 | 165 | 0.680 |
Why?
|
Piperazines | 9 | 2024 | 2511 | 0.580 |
Why?
|
Diarrhea, Infantile | 1 | 2016 | 101 | 0.530 |
Why?
|
Congenital Abnormalities | 2 | 2024 | 704 | 0.510 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2021 | 1895 | 0.500 |
Why?
|
Postpartum Period | 2 | 2024 | 1167 | 0.490 |
Why?
|
Infant Formula | 1 | 2016 | 193 | 0.480 |
Why?
|
Breast Feeding | 3 | 2021 | 1355 | 0.480 |
Why?
|
Infant, Newborn | 24 | 2024 | 26183 | 0.460 |
Why?
|
Child Mortality | 1 | 2016 | 205 | 0.460 |
Why?
|
Alkynes | 4 | 2020 | 312 | 0.460 |
Why?
|
Cyclopropanes | 4 | 2020 | 431 | 0.440 |
Why?
|
Respiratory System | 1 | 2016 | 557 | 0.420 |
Why?
|
Gestational Age | 2 | 2019 | 3565 | 0.420 |
Why?
|
Pregnancy Complications | 6 | 2023 | 2942 | 0.400 |
Why?
|
Drug Therapy, Combination | 5 | 2019 | 6293 | 0.370 |
Why?
|
Zidovudine | 3 | 2017 | 624 | 0.360 |
Why?
|
Hypertension, Pregnancy-Induced | 3 | 2023 | 517 | 0.360 |
Why?
|
Mothers | 3 | 2020 | 2189 | 0.360 |
Why?
|
Female | 53 | 2024 | 390323 | 0.300 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2013 | 833 | 0.280 |
Why?
|
Pneumonia | 2 | 2019 | 2129 | 0.260 |
Why?
|
Pregnant Women | 4 | 2023 | 562 | 0.260 |
Why?
|
Infant | 16 | 2024 | 36055 | 0.250 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2496 | 0.240 |
Why?
|
Maternal Mortality | 2 | 2024 | 300 | 0.240 |
Why?
|
Hospital Mortality | 2 | 2019 | 5272 | 0.230 |
Why?
|
Prevalence | 7 | 2024 | 15651 | 0.210 |
Why?
|
Humans | 56 | 2024 | 758406 | 0.210 |
Why?
|
HIV-1 | 5 | 2024 | 6850 | 0.210 |
Why?
|
Infant, Small for Gestational Age | 3 | 2021 | 460 | 0.190 |
Why?
|
Polydactyly | 1 | 2021 | 56 | 0.180 |
Why?
|
HIV Protease Inhibitors | 1 | 2022 | 432 | 0.170 |
Why?
|
Pregnancy Trimester, First | 1 | 2024 | 908 | 0.170 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 131 | 0.170 |
Why?
|
Adult | 26 | 2024 | 219935 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 176 | 0.160 |
Why?
|
Obstetric Labor, Premature | 1 | 2020 | 274 | 0.150 |
Why?
|
Hospitals, District | 1 | 2019 | 113 | 0.150 |
Why?
|
Lymphopenia | 1 | 2020 | 280 | 0.150 |
Why?
|
HIV | 5 | 2022 | 1581 | 0.140 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2020 | 619 | 0.140 |
Why?
|
Africa | 1 | 2019 | 706 | 0.140 |
Why?
|
Syphilis | 1 | 2019 | 243 | 0.140 |
Why?
|
Fetal Death | 1 | 2018 | 434 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2020 | 583 | 0.130 |
Why?
|
Antimalarials | 1 | 2022 | 905 | 0.130 |
Why?
|
Virus Diseases | 1 | 2021 | 719 | 0.130 |
Why?
|
Prenatal Care | 2 | 2020 | 1129 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1557 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1931 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2023 | 1160 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2111 | 0.110 |
Why?
|
Infant, Low Birth Weight | 1 | 2018 | 859 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1227 | 0.110 |
Why?
|
Travel | 1 | 2019 | 785 | 0.110 |
Why?
|
Causality | 1 | 2019 | 1241 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2836 | 0.110 |
Why?
|
Young Adult | 12 | 2024 | 58808 | 0.110 |
Why?
|
Malaria | 1 | 2022 | 1226 | 0.100 |
Why?
|
Shock, Septic | 1 | 2019 | 761 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2022 | 3056 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2019 | 831 | 0.100 |
Why?
|
Population Surveillance | 2 | 2019 | 2606 | 0.100 |
Why?
|
Fetus | 1 | 2019 | 1859 | 0.100 |
Why?
|
Anemia | 1 | 2021 | 1504 | 0.100 |
Why?
|
Child | 5 | 2023 | 79818 | 0.100 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12440 | 0.090 |
Why?
|
Alanine | 2 | 2024 | 603 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4839 | 0.090 |
Why?
|
Feces | 1 | 2016 | 1456 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3142 | 0.080 |
Why?
|
Prospective Studies | 5 | 2020 | 54137 | 0.080 |
Why?
|
Medication Adherence | 2 | 2018 | 2155 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2013 | 2925 | 0.080 |
Why?
|
Risk Assessment | 3 | 2018 | 23884 | 0.070 |
Why?
|
Cause of Death | 2 | 2019 | 3675 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7403 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7818 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2197 | 0.060 |
Why?
|
Folic Acid | 2 | 2022 | 1309 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5404 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3846 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10652 | 0.060 |
Why?
|
Risk Factors | 5 | 2023 | 73809 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4673 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10112 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10146 | 0.060 |
Why?
|
Clinical Competence | 1 | 2019 | 4775 | 0.050 |
Why?
|
Iron | 2 | 2022 | 1786 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2021 | 22029 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Fertilization | 1 | 2023 | 197 | 0.050 |
Why?
|
Compassionate Use Trials | 1 | 2021 | 50 | 0.050 |
Why?
|
Chloroquine | 1 | 2022 | 274 | 0.050 |
Why?
|
Iron-Binding Proteins | 1 | 2021 | 79 | 0.050 |
Why?
|
E-Selectin | 1 | 2023 | 576 | 0.050 |
Why?
|
Teratogens | 1 | 2021 | 117 | 0.040 |
Why?
|
Ritonavir | 1 | 2022 | 328 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2023 | 691 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 228 | 0.040 |
Why?
|
Toes | 1 | 2021 | 209 | 0.040 |
Why?
|
Vitamin B 6 | 1 | 2021 | 233 | 0.040 |
Why?
|
Cervical Length Measurement | 1 | 2020 | 45 | 0.040 |
Why?
|
Clinical Audit | 1 | 2019 | 30 | 0.040 |
Why?
|
Micronutrients | 1 | 2022 | 381 | 0.040 |
Why?
|
Male | 9 | 2024 | 358747 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1125 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 706 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 377 | 0.040 |
Why?
|
Patients' Rooms | 1 | 2019 | 61 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2021 | 582 | 0.040 |
Why?
|
Adenine | 1 | 2024 | 975 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 597 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 778 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2021 | 522 | 0.040 |
Why?
|
Fingers | 1 | 2021 | 506 | 0.040 |
Why?
|
Selection Bias | 1 | 2019 | 357 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 41256 | 0.040 |
Why?
|
Placebos | 1 | 2021 | 1661 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2021 | 12262 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2020 | 732 | 0.040 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2021 | 914 | 0.040 |
Why?
|
Zinc | 1 | 2021 | 687 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2021 | 368 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2021 | 604 | 0.030 |
Why?
|
Tachycardia | 1 | 2019 | 600 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14490 | 0.030 |
Why?
|
Pulmonary Edema | 1 | 2019 | 408 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1754 | 0.030 |
Why?
|
Parturition | 1 | 2019 | 446 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2022 | 1300 | 0.030 |
Why?
|
Labor, Induced | 1 | 2016 | 151 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 578 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39059 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2097 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2020 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 842 | 0.030 |
Why?
|
Weight Gain | 1 | 2024 | 2346 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1702 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 42062 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2020 | 932 | 0.030 |
Why?
|
Hypotension | 1 | 2019 | 879 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2017 | 594 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3321 | 0.030 |
Why?
|
Health Services Research | 1 | 2019 | 1812 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1067 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2016 | 0.020 |
Why?
|
United States | 3 | 2024 | 72136 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1230 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3812 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3387 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5098 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4353 | 0.020 |
Why?
|
Drug Utilization | 1 | 2015 | 1187 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2504 | 0.020 |
Why?
|
Poverty | 1 | 2018 | 2692 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 80168 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23679 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9160 | 0.020 |
Why?
|
Public Health | 1 | 2018 | 2658 | 0.020 |
Why?
|
Adolescent | 2 | 2022 | 87892 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 219568 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7378 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25956 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15785 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58683 | 0.010 |
Why?
|
Animals | 1 | 2021 | 167768 | 0.010 |
Why?
|
Aged | 1 | 2019 | 168218 | 0.000 |
Why?
|
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_